Alx Oncology Holdings (ALXO) Total Liabilities (2019 - 2026)

Alx Oncology Holdings' Total Liabilities history runs 8 years deep, the most recent figure standing at $27.0 million for Q1 2026.

• In Q1 2026, Total Liabilities fell 17.25% year-over-year to $27.0 million; the TTM figure through Mar 2026 stood at $27.0 million (down 17.25% YoY), while the FY2025 annual figure was $33.1 million, down 3.2% from the prior year.
• Total Liabilities came in at $27.0 million for Q1 2026 at Alx Oncology Holdings, down from $33.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $55.3 million in Q2 2024 to a low of $20.1 million in Q1 2022.
• A 5-year average of $38.1 million and a median of $34.2 million in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities soared 151.11% in 2022 and tumbled 44.11% in 2025, its largest moves.
• Alx Oncology Holdings' Total Liabilities stood at $43.0 million in 2022, then grew by 22.81% to $52.8 million in 2023, then plunged by 35.36% to $34.2 million in 2024, then declined by 3.2% to $33.1 million in 2025, then slipped by 18.4% to $27.0 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $27.0 million, $33.1 million, and $37.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison